Diseases causing exudative RD include uveal melanoma, Vogt-Koyanagi-Harada syndrome ... Note the small amount of adjacent vitreous hemorrhage. Diagram depicting a single horseshoe retinal tear ...

This case report details two instances of gastrointestinal (GI) involvement in metastatic melanoma. The first patient ... investigation results, drawing original diagrams and algorithms and critical ...

Consort diagram). Mean age was 61 years (range 44 – 76 years), with a male predominance (75%). Primary tumor disease included lung cancer (n=5, NSCLC=4, SCLC=1), malignant melanoma (n=4), glioblastoma ...

Teddi Mellencamp's diagnosis with melanoma in 2022 was just the beginning of a multi-year cancer journey that's ongoing. The 43-year-old, who previously appeared on “The Real Housewives of ...

Nodular melanoma is a type of skin cancer. It’s a dangerous form of melanoma that grows quickly. Only about 15% of all melanomas are nodular. But it causes nearly half of melanoma-related deaths.

Uveal melanoma, or ocular melanoma, is a cancer that happens inside your eyeball. It’s rare. Just 7 out of every 1 million people get it each year. But it’s also the most common eye cancer for ...

Schematic diagram illustrating the two-strategy evaluation framework implemented in our study. Credit: npj Digital Medicine (2025). DOI: 10.1038/s41746-025-01560-y ...

TFE3 fusion proteins are the oncogenic drivers of translocation renal cell carcinoma but their mechanism of action remains ...

Get Instant Summarized Text (Gist) Research using zebrafish has identified the protein Wdr5 as essential for maintaining genomic integrity in hematopoietic stem and progenitor cells (HSPCs) during ...

Melanoma is the most serious type of skin cancer. It develops when skin cells multiply rapidly as a consequence of mutations in their DNA caused by UV exposure. Melanomas originate in the pigment ...

Bristol Myers Squibb has reported disappointing results for its checkpoint inhibitor combination Opdualag in melanoma, dashing its hopes of moving the drug earlier in the treatment pathway.